Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia ...
The companies developing new weight-loss medicines have a problem: the balance of power has shifted, and patients are bailing ...
Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.
Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent deals ...
The Department of Health and Human Services on Wednesday announced several initiatives to try and reduce reliance on animal testing in drug development. The Food an ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results